Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays.
Journal
Drug metabolism and disposition: the biological fate of chemicals
ISSN: 1521-009X
Titre abrégé: Drug Metab Dispos
Pays: United States
ID NLM: 9421550
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
08
12
2021
accepted:
04
04
2022
pubmed:
1
5
2022
medline:
2
7
2022
entrez:
30
4
2022
Statut:
ppublish
Résumé
The multidrug resistance protein 1 (MDR1) P-glycoprotein (P-gp) is a clinically important transporter. In vitro P-gp inhibition assays have been routinely conducted to predict the potential for clinical drug-drug interactions (DDIs) mediated by P-gp. However, high interlaboratory and intersystem variability of P-gp IC
Identifiants
pubmed: 35489778
pii: dmd.121.000807
doi: 10.1124/dmd.121.000807
doi:
Substances chimiques
ATP Binding Cassette Transporter, Subfamily B
0
ATP Binding Cassette Transporter, Subfamily B, Member 1
0
Digoxin
73K4184T59
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
909-922Informations de copyright
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics.